Towards a more mechanistic understanding of traits and range sizes

ABSTRACT Aim An important, unresolved question in macroecology is to understand the immense inter-specific variation in geographic range sizes. While species traits such as fecundity or body size are thought to affect range sizes, a general understanding on how multiple traits jointly influence them is missing. Here, we test the influence of a multitude of species traits on global range sizes of European passerine birds in order to better understand possible mechanisms behind macroecological relationships. Location Global. Methods We evaluated the effect of life-history traits (fecundity, dispersal ability), ecological traits (habitat niche, diet niche, migratory behaviour, migratory flexibility) and a morphological trait (body size) on the global range sizes of 165 European passerines. We identified hypotheses from the literature relating traits to range size and used path analysis to test them. Results Fecundity, dispersal ability and habitat niche breadth had a direct positive effect on range size. Diet niche position had a direct negative effect on range size. Habitat niche breadth also had an indirect positive effect via higher fecundity. Migratory behaviour had an indirect positive effect via better dispersal ability. Body size had a strong positive direct effect which was reduced by negative indirect effects via several other traits. Main conclusions Geographic range sizes of European passerines were influenced by life-history traits (fecundity and dispersal ability), ecological traits (habitat niche breadth, diet niche position and migratory behaviour) and by body size. Traits influenced range size both directly and indirectly. Body size effects were particularly complex, with positive and negative effects acting over different pathways. We show that it is necessary to disentangle the direct and indirect influence of multiple traits on range size to better elucidate the mechanisms that generate macroecological relationships

Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.

BACKGROUND/AIM Metastatic colorectal cancer (mCRC) is a heterogeneous disease with distinct molecular subtypes. The BRAFV600E-mutation found in approximately 8-12% of mCRC patients is associated with poor prognosis. Guideline recommendations for this population are mostly based on small cohorts due to lack of clinical data. This retrospective analysis was designed to evaluate (approved) therapeutic approaches and algorithms in BRAFV600E-mutant mCRC prior to approval of the targeted combination encorafenib plus cetuximab in Germany, Austria, and Switzerland. PATIENTS AND METHODS Anonymized data from BRAFV600E-mutant mCRC patients were analyzed retrospectively regarding 1st-, 2nd- and 3rd-line treatment using descriptive statistics. RESULTS Forty-two patients were eligible for analysis (mean age 62.1 years, 47.6% female). At initial diagnosis, 20 patients (47.6%) were documented with right-sided tumors. Most patients (81.0%) were tested for BRAF before 1st-line. Four patients (9.5%) showed high microsatellite instability (MSI-H). Based on 94 treatment lines, chemotherapy combined with targeted therapy (TT) was used mostly (61.7%), followed by chemotherapy alone (19.1%). Backbone therapies were most frequently FOLFOXIRI (27.7%), FOLFOX/CAPOX (22.3%), or FOLFIRI (20.2%). Anti-VEGF/VEGFR and anti-EGFR-treatments were used in 45.7% and 23.4% of patients, respectively. Across all treatment lines and types, the predominantly documented reason for discontinuation was lack of efficacy. CONCLUSION Combined chemotherapy+TT (anti-VEGF/VEGFR and anti-EGFR) played a predominant role in BRAFV600E-mutated mCRC treatment prior to approval of the targeted combination encorafenib plus cetuximab. Since lack of efficacy was the major reason for treatment discontinuation, newly approved therapies including encorafenib plus cetuximab and - for MSI-H tumors - pembrolizumab represent urgently needed options for future mCRC patients

Les compétences des sages-femmes selon la loi

Deutsch: Seit Anfang Jahr ist das Gesundheitsberufegesetz in Kraft und definiert die Kom­petenzen von Hebammen und sechs weiteren Berufsgruppen. Ein Gesetz regelt nicht nur Pflichten, es beinhaltet auch Rechte und bietet Schutz. Entstanden ist es in mehrjähriger, intensiver Zusammenarbeit von Behörden und Vertreterinnen aus der Berufskonferenz sowie unter Einbezug von Hebammen aus verschiedenen Bereichen der Praxis und der Lehre. Sie haben mit grosser Umsicht und Sorgfalt die grund­legenden Formulierungen erarbeitet und in den Vernehmlassungen verteidigt Français: La loi sur les professions de la santé est en vigueur depuis le début de l’année et définit les compétences des sages-femmes et de six autres professions. Une telle loi règle non seulement les devoirs mais aussi les droits et offre une protection. Elle a été créée après plusieurs années de coopération intensive entre les autorités et les représentants de la Conférence professionnelle ainsi qu'avec la participation de sages-femmes de divers domaines de la pratique et de l'enseignement. Celles-ci ont élaboré les formulations de base avec grand soin et diligence et les ont défendues lors des consultations